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Dissociation of the diurnal variation of aldosterone and cortisol
in anephric subjects. Diurnal variation of plasma aldosterone and
cortisol concentration in man was studied in 13 anephric subjects
and 7 normal subjects. All subjects were ambulatory and active
throughout the study except during an 8-hour sleep period. Six
anephric subjects received Kayexalate® (sodium polystyrene
sulfonate) during the studies to prevent potassium accumulation
and increase in plasma potassium concentration. Diurnal varia-
tion of plasma aldosterone concentration with peak and nadir
concentrations at 12:00 noon and 12:00 midnight respectively
was demonstrated in the studies on normal subjects. Changes in
plasma aldosterone concentration were not significantly corre-
lated with changes in plasma cortisol concentration but were
highly correlated with changes in PRA (P <0.001). There was a
highly significant correlation between plasma aldosterone and
potassium concentration in the anephric subjects studied without
Kayexalate® administration (P < 0.001). In the anephric sub-
jects who received Kayexalate®, plasma aldosterone and potas-
sium concentration remained stable, and no correlation could be
demonstrated. No diurnal variation of plasma aldosterone con-
centration could be demonstrated in either group of anephric
subjects, whereas plasma cortisol concentration varied as in the
studies on normal subjects. Conclusion. Diurnal variation of
plasma aldosterone concentration is dependent on continued
stimulation by the renin-angiotensin system. Loss of this stimu-
lation has no demonstrable effect on the diurnal variation of
plasma cortisol concentration.
Dissociation des variations nycthémerales de l'aldosterone et
du cortisol chez les sujets anéphriques. Les variations nycthéme-
rales de l'aldostérone et du cortisol plasmatiques chez l'homme
ont été étudiées chez 13 sujets anéphriques et 7 sujets normaux.
Tous les sujets étaient ambulatoires excepté pendant une pé-
node de sommeil de 8 heures. Six sujets anéphriques receivaient
du Kayexalate® (sodium polystyrene sulfonate) afin d'em-
pécher une accumulation de potassium et une augmentation de
la kaliémie. Des variations nycthémérales de l'aldostéronémie
avec un pic et un nadir a midi et minuit, respectivement, ont
dté observées chez les sujets normaux. Les modifications de
l'aldostéronémie ne sont pas significativement corrélées avec
les modifications du cortisol plasmatique mais trés corrélées
avec celles de PRA (P < 0,001). II existe une correlation trés
significative entre l'aldostéronémie et la kaliëmie chez les sujets
anéphriques étudiés en dehors de l'administration de Kayexalate
(P < 0,001). Chez les sujets anéphriques recevant dii Kayexalate
l'aldostéronémie et la kaliémie sont stables et aucune cor-
relation n'est obtenue. Aucune variation nycthemerale de l'aldo-
stéronémie n'a Cté observe dans les groupes de sujets anéphriques
alors que Ia concentration de cortisol plasmatique vane comme
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chez les sujets normaux. Ii peut étre conclu de ces etudes que
les variations nycthemerales de l'aldostëronémie dependent de la
stimulation par le systéme renine-angiotensine. La perte de cette
stimulation n'a pas d'effet sur Ia cortisoldmie.
At least three factors play a role in the regulation
of aldosterone secretion: (1) sodium or volume-re-
lated stimuli mediated by the renin-angiotensin sys-
tem, (2) potassium, and (3) adrenocorticotropic hor-
mone (ACTH). The role of the renin-angiotensin
system with regard to volume regulation and the
control of aldosterone secretion is well established
[1-4]. Modulation of aldosterone secretion by
plasma potassium concentration also has been
shown clearly in previous studies [5—10]. The role of
ACTH is less certain. Stimulation of aldosterone se-
cretion by ACTH has been demonstrated in acute
infusion studies [11—14], although often these stud-
ies have been performed with greater than physio-
logic quantities of ACTH. Although observations in
such studies may be indicative of the response to
acute stress [15], they do not elucidate the role of
ACTH in the daily regulation of aldosterone secre-
tion. On the other hand, Kern et a! have shown that
infusion of ACTH in physiologic quantities increas-
es plasma aldosterone concentration in dexametha-
sone-suppressed subjects [16]. ACTH infusion also
enhanced the response to sodium restriction in
these subjects, which suggests that ACTH plays a
permissive role in the regulation of aldosterone se-
cretion.
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Diurnal variation of aldosterone secretion and
plasma aldosterone concentration has been demon-
strated in previously reported studies [17—22]. The
possibility that these rhythmic diurnal changes may
be ACTH-dependent has been suggested by the
similarity of concomitant diurnal changes in plasma
cortisol concentration [23, 24]. Diurnal variation of
plasma aldosterone concentration, however, also
resembles the diurnal variation of PRA [18, 19,
21, 22]. Thus, the diurnal variation of plasma al-
dosterone and cortisol concentration could be asso-
ciated with two different control mechanisms with
similar rhythmic characteristics, or, alternatively,
the effects of ACTH and the renin-angiotensin sys-
tem on aldosterone secretion could be interrelated
in some manner.
To further evaluate these possibilities, we have
studied the diurnal variation of plasma aldosterone
and cortisol concentration in anephric subjects,
thereby excluding the effect of the renin-angiotensin
system, and have compared the data from these
studies with those obtained from comparable stud-
ies on normal subjects. The relationship between
plasma aldosterone concentration and plasma po-
tassium concentration in both anephric and normal
subjects was also investigated in these studies.
Methods
Thirteen anephric subjects were admitted for
studies to the Clinical Research Unit following he-
modialysis, which was terminated at approximately
2:00 P.M. on the day of admission in all subjects.
Six subjects were females and seven were males;
their ages ranged from 21 to 52 years. Total fluid
intake was restricted to 500 ml/day to minimize
changes in body weight, and dietary sodium and po-
tassium intake were restricted to 20 mEq and 40
mEq/day, respectively. Six subjects, two females
and four males, were given Kayexalate® (sodium
polystyrene sulfonate), 7.5 g orally at 9:00 P.M. on
the day of admission and at 8:00 A.M., 2:00 P.M.,
and 8:00 P.M. Ofl the following day to prevent potas-
sium accumulation and an increase in plasma potas-
sium concentration during the studies. The other
anephric subjects were studied without Kayexalate
administration.
Seven normal subjects, all males ranging in age
from 27 to 44 years, were admitted for similar stud-
ies. Diets and fluid intake were unrestricted; 24-
hour urinary sodium excretion was determined as
an index of dietary sodium intake. None of the nor-
mal subjects received Kayexalate. In other re-
spects, the study protocols for anephric and normal
subjects were identical.
On the morning following admission, the subjects
were awakened at 7:00 A.M., weighed, and served
breakfast. They remained up and active throughout
the day and went to bed at 11:00 P.M. to sleep until
7:00 A.M. the following morning. They were awak-
ened again at 7:00 A.M., were weighed, and were
out of bed and active within the Clinical Research
Unit until the studies were terminated at 9:00 AM.
on day 2. Blood samples for determination of PRA,
plasma aldosterone, cortisol, sodium, and potas-
sium concentrations were obtained at 9:00 A.M. on
day 1 and every 3 hours through 9:00 A.M. on day 2.
All blood samples were drawn through a small in-
dwelling needle in a forearm or antecubital vein,
permitting the collection of samples with minimal
disturbance of sleeping subjects. All subjects slept
in a darkened room, and blood samples obtained
during the hours of sleep were drawn in the light of
a small bedside lamp. There were no differences in
sleep time or brief exposure to light during blood
drawing between the studies on normal subjects and
the studies on anephric subjects.
Blood for determination of PRA was drawn into
chilled syringes containing EDTA and promptly
centrifuged at 40 C. All blood samples for determi-
nation of plasma aldosterone, cortisol, sodium, and
potassium concentrations were collected in hepari-
nized syringes. The methods used in the determina-
tion of PRA [25] and plasma aldosterone concentra-
tion [9] have been described in previous communi-
cations. The lower limit of sensitivity in our assay
for PRA using a 3-hour incubation at a pH of 7.4 is
0.1 ng angiotensin I generated/ml/hr. In six replicate
determinations performed on purified human renin
(1 x 10 Goldblatt U) added to anephric human
plasma, the mean quantity of angiotensin I gener-
ated was 4.6 (SD) 0.3 ng/ml/hr. Determinations of
plasma aldosterone concentration were performed
on 2 ml of plasma following dichloromethane ex-
traction and paper chromatography in a ben-
zene:methanol:water (100:50:50) solvent system. A
charcoal-extracted aliquot of the eluted sample was
assayed as a "blank" with each determination. This
method distinguishes between 0 and 50 pg (P <
0.01) and between 25 and 50 pg (P < 0.05) of al-
dosterone added to 5 ml of plasma from an adrenal-
ectomized patient (N = 20 samples in each com-
parison). The relationship between observed and
expected concentrations of aldosterone added to
plasma from an adrenalectomized patient is linear
and highly correlated (P < 0.001) over a range be-
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centrations every 3 hours beginning at 9:00 A.M. on
day 1 and ending at 9:00 A.M. on day 2 are shown in
Fig. 1. The relationship between measured values
of plasma aldosterone and cortisol concentration
and between these and PRA, as well as the relation-
ship between the interval changes in these parame-
ters, was examined statistically. From a peak con-
centration at 12:00 noon on day 1, plasma aldoster-
one concentration decreased to significantly lower
concentrations at 6:00 P.M. (P < 0.005), 9:00 P.M.
(P < 0.005), and 12:00 midnight (P < 0.01) and in-
creased progressively in subsequent intervals
through 9:00 A.M. on day 2. Although a positive cor-
relation between measured values of plasma al-
dosterone and cortisol concentrations could be
demonstrated (r = +0.292, P < 0.05, N = 60),
changes in plasma aldosterone concentrations were
not concordant with the changes in plasma cortisol
concentrations (r = +0.155, P > 0.1, N = 53). In
contrast, there was a highly significant correlation
(r= +0.441,P<0.001,N= 55)betweenchangesin
plasma aldosterone concentrations and changes in
PRA (Fig. 2). Measured values of plasma aldoster-
one concentrations and PRA were also significantly
correlated (r = +0.596, P < 0.001, N = 62). No
correlation between plasma cortisol concentrations
and PRA could be demonstrated.
Plasma aldosterone concentrations were not sig-
nificantly correlated with plasma potassium concen-
trations, which decreased from 4.3 (sEM) 0.13
mEq/liter at 12:00 noon to 3.9 0.16 mEq/liter at
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Fig. 1. Plasma aldosterone and cortisol concentrations, PRA,
and plasma potassium concentrations every 3 hours during the
24-hour study period in normal subjects. Bars represent mean
concentrations 1 SEM.
tween 0.5 and 5.0 ngIlOO ml. Plasma cortisol con-
centration was measured by the competitive pro-
tein-binding radioassay of Hsu and Bledsoe [26]. In-
terassay and intraassay variation in this assay is 7.2
and 5.1%, respectively. Plasma sodium and potas-
sium concentrations and urinary sodium concentra-
tions in the studies on normal subjects were deter-
mined by autoanalyzer flame photometry.
Results
Normal subjects. Plasma aldosterone and cortisol
concentrations, PRA, and plasma potassium con-
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Fig. 2. Correlation between the changes in plasma aldosterone
concentrations and changes in PRA in normal subjects.
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12:00 midnight (P < 0.001). There also was no sig-
nificant correlation between plasma potassium con-
centrations and plasma cortisol concentrations. No
variation could be demonstrated in plasma sodium
concentrations; urinary sodium excretion, which
served as an index of sodium intakes, ranged from
104 to 265 mEqI24 hours. Body weights were not
changed.
Anephric subjects studied without Kayexalate
administration. Plasma aldosterone concentrations
every 3 hours beginning at 9:00 A.M. on day 1 and
ending at 9:00 A.M. on day 2 are shown with plasma
cortisol and potassium concentrations in Fig. 3. No
PRA could be detected. There were no significant
variations in plasma aldosterone concentrations, al-
though plasma cortisol concentrations varied as
they did in normal subjects, decreasing from a peak
concentration at 9:00 A.M. on day 1, to low concen-
trations at 12:00 midnight and 3:00 A.M., and in-
creasing later in the morning through 9:00 A.M. On
day 2. No correlation between plasma cortisol con-
centrations and plasma aldosterone concentrations
could be demonstrated.
Plasma potassium concentration increased from
4.5 (sUM) 0.3 mEq/liter at 9:00 A.M. on day 1 to
5.2 0.2 mEq/liter at 9:00 A.M. on day 2 (P <
0.001). Although no correlation between 3-hour in-
terval changes in plasma potassium and aldosterone
concentrations could be demonstrated, an effect of
plasma potassium on plasma aldosterone concen-
trations was suggested by the highly significant cor-
relation of the measured concentrations of these pa-
rameters (r = +0.666, P < 0.001, N = 63).
Changes in body weight during the studies ranged
from — 1.1 to +0.2 kg (mean change in body weight,
—0.57 [sEM] 0.17 kg). Plasma sodium concentra-
tions were not altered.
Anephric subjects who received Kayexalate.
Plasma aldosterone, cortisol, and potassium con-
centrations every 3 hours beginning at 9:00 A.M. on
day I and ending at 9:00 A.M. on day 2 are shown in
Fig. 4. As in the anephric subjects studied without
Kayexalate administration, no PRA could be de-
tected. There was no significant change in plasma
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Fig. 3. Plasma aldosierone, cortisol, and potassium concentra-
tions every 3 hours during the 24-hour study period in anephric
subjects studied without Kayexalate administration. Bars repre-
sent mean concentrations 1 SEM.
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Fig. 4. Plasma aldosterone, cortisol, and potassium concentra-
tions every 3 hours during the 24-hour study period in anephric
subjects who received Kayexalate. Bars represent mean concen-
trations 1 SEM.
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aldosterone concentrations, which remained stable
throughout the studies despite the changes in pos-
ture and activity of the subjects. Mean plasma al-
dosterone concentration during the studies was
3.4 (sEM) 0.3 ngIlOO ml, whereas the mean plasma
aldosterone concentration in the anephric subjects
who did not receive Kayexalate was 4.9 (sEM) 0.4
ng/l00 ml (P < 0.005).
There was no increase in plasma potassium con-
centration which was 4.0 (sEM) 0.1 rnEq/liter at
9:00 A.M. on day 1 and 3.9 (sEM) 0.1 mEq/liter at
9:00 A.M. on day 2. Under these conditions, the cor-
relation of plasma aldosterone with plasma potas-
sium concentrations was not demonstrated.
Diurnal variation of plasma cortisol concentra-
tions persisted without change. No significant dif-
ferences in plasma cortisol concentrations between
anephric subjects who received Kayexalate and
those who did not could be demonstrated. There
were no correlations between plasma cortisol con-
centrations and either plasma potassium or plasma
aldosterone concentrations.
Mean change in body weight was +0.68 (sEM)
0.14 kg. No change occurred in plasma sodium con-
centration.
Discussion
Diurnal variation of plasma aldostercne concen-
tration resembling the diurnal variation of plasma
cortisol concentration and PRA was demonstrated
in our studies on normal subjects. Similar observa-
tions were reported by Grim et al who also found
that plasma aldosterone concentration in normal
ambulatory subjects increased to a peak level at
12:00 noon and decreased progressively from 12:00
noon through 12:00 midnight [22]. A similar pattern,
but with an early morning peak, was observed in
studies on recumbent subjects by Grim et al [22]
and Kunita et al [21]. Katz, Romffi, and Smith
found that plasma aldosterone concentrations in re-
cumbent subjects increased during sleep and
reached their highest concentrations in the late
sleep and early awake hours [19]. In these studies,
plasma aldosterone concentrations correlated with
both plasma cortisol concentrations and PRA. The
early morning increases in plasma aldosterone con-
centrations and PRA, however, persisted in dexa-
methasone-suppressed subjects, but the increases
in plasma cortisol concentrations were abolished.
In studies on sodium-restricted recumbent subjects,
Vagnucci et al found that plasma aldosterone con-
centrations increased in the early hours of sleep,
whereas plasma cortisol and corticosterone concen-
trations increased in the terminal portion of the
sleep period [18]. Similar dissociation of the
changes in plasma aldosterone and cortisol concen-
trations during sleep was observed in our studies. In
addition, the various 3-hour interval changes in
plasma aldosterone concentrations were correlated
with changes in PRA but not with concurrent
changes in plasma cortisol concentrations.
No diurnal variation of plasma aldosterone con-
centration could be demonstrated in the studies on
anephric subjects. In the subjects who were studied
without Kayexalate administration, slight increases
in plasma aldosterone concentrations were ob-
served in the latter half of the study period. These
increases, although not statistically significant,
coincided with progressive increases in plasma po-
tassium concentrations. Vetter et al also observed
increases in plasma aldosterone concentrations in
the early morning hours between 2:00 A.M. and 6:00
A.M. in studies on recumbent anephric subjects
[27]. Although changes in plasma potassium con-
centrations were small in these studies by Vetter et
al, our earlier studies on anephric subjects [9] and
studies reported by McCaa, McCaa, and Guyton
[10] suggest that they were large enough to account
for increases in plasma aldosterone concentrations.
In our studies without Kayexalate, plasma al-
dosterone concentrations and plasma potassium
concentrations were significantly correlated. This
correlation was abolished in the anephric subjects
who received Kayexalate, by maintaining their
plasma potassium concentrations at constant levels
throughout the studies. Differences in plasma al-
dosterone concentrations between the anephric
subjects who received Kayexalate and those who
did not can also be attributed to the differences in
plasma potassium concentrations in the two groups.
Mean plasma aldosterone concentration was 4.9
(sEM) 0.4 ng/100 ml in the anephric subjects studied
without Kayexalate administration and 3.4 0.3
ng!l00 ml in those who received Kayexalate. Lower
values were reported by Sealey et al [28], but the
anephric subjects in their studies were usually he-
modialyzed with potassium-free dialysate, whereas
the dialysate potassium concentration used routine-
ly in the hemodialysis of our subjects was 2.0 mEqi
liter. Plasma aldosterone concentrations similar to
those reported by Sealey et al [28] were observed
by Weidmann et al in anephric subjects who were
studied following hemodialysis with either potas-
sium-free dialy sate or 1.0 mEq/liter dialysate potas-
sium concentration [29]. Mean plasma aldosterone
concentration in ten anephric subjects whose
plasma potassium concentrations ranged from 2.7
to 4.0 mEq/liter in these studies was 1.18 ng!100 ml.
This evidence of regulation of plasma aldosterone
concentration by potassium in the anephric subject
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is consistent with our previously reported observa-
tions [8, 9] which suggest that potassium is the pri-
mary regulator of plasma aldosterone concentration
in the absence of the renin-angiotensin system.
Plasma aldosterone concentrations in the aneph-
nc subjects who received Kayexalate, although
lower than they were in the anephric subjects stud-
ied without Kayexalate administration, were higher
than the nadir concentrations in normal subjects at
9:00 P.M. and 12:00 midnight (P < 0.05). This can-
not be attributed to a difference in plasma potas-
sium concentrations, which, in this group of aneph-
nc subjects, were almost identical to the concentra-
tions observed in the normal subjects at these
times. It is possible, however, that the sensitivity of
aldosterone secretion to potassium is increased in
the anephric subject, either because of the absence
of other stimuli or due to repeated elevations of
plasma potassium concentrations between dialyses.
It should be noted in this regard that plasma al-
dosterone concentrations similar to those occurring
at 9:00 P.M. and 12:00 midnight in our studies on
normal subjects were observed by Sealey et al [28]
and Weidmann et al [29] in their studies on anephric
subjects with low plasma potassium concentrations.
Plasma aldosterone concentrations in the aneph-
nc subjects who received Kayexalate were also
lower (P < 0.05) than were the peak concentrations
which occurred in the normal subjects at 12:00
noon. This failure of plasma aldosterone concentra-
tions in the anephric subjects to increase to the mid-
day concentrations observed in normal subjects is
consistent with either the loss of stimulation that
produces rhythmic diurnal changes in plasma a!-
dosterone concentrations in normal subjects or de-
creased responsiveness to this stimulation. Clearly,
the mechanism responsible for the diurnal variation
of plasma cortisol concentrations remains intact in
anephric subjects.
Although these studies suggest that the mecha-
nism responsible for diurnal variation of plasma al-
dosterone concentrations in normal subjects could
be different from that responsible for the diurnal
variation of plasma cortisol concentrations, they do
not exclude the possibility that the mechanisms are
interrelated in some manner. It could be argued, for
example, that the response of aldosterone secretion
to ACTH is dependent on continued stimulation by
the renin-angiotensin system. Studies by several in-
vestigators have shown previously that the re-
sponse of aldosterone secretion to ACTH adminis-
tration, as shown by the degree of change in plasma
aldosterone concentration, is reduced in anephric
subjects [29—32]. Several factors, however, in addi-
tion to loss of stimulation by the renin-angiotensin
system, may influence the response of aldosterone
secretion to ACTH in anephric subjects. One of
these factors, as shown by the studies of Weidmann
et al, is plasma potassium concentration [29]. These
investigators found that ACTH administration pro-
duced little or no change in plasma aldosterone con-
centrations in anephric subjects whose plasma po-
tassium concentrations were low (2.5 to 4.0 mEqi
liter) due to prior hemodialyses with low-potassium
or potassium-free dialysate. Hemodialyses with
higher dialysate potassium concentrations resulted
in higher plasma potassium concentrations and
marked enhancement of the plasma aldosterone re-
sponse to ACTH.
Plasma potassium concentrations in our studies,
especially in the subjects studied without Kay-
exalate administration, were such that the sensitivi-
ty of aldosterone secretion to ACTH should not
have been reduced on this basis. The only dis-
cernible factor accounting for the loss of diurnal
variation of plasma aldosterone concentration in
the anephric subjects in our studies is the lack of
stimulation by the renin-angiotensin system.
Whether the loss of diurnal variation of plasma al-
dosterone concentrations in these subjects is a re-
flection of decreased sensitivity to ACTH or in-
dicates that the renin-angiotensin system rather
than ACTH is responsible for the diurnal variation
of plasma aldosterone concentrations in normal
subjects is uncertain. These studies show, however,
that diurnal variation of plasma aldosterone concen-
trations depends on continued stimulation by the re-
nin-angiotensin system, whereas loss of this stimu-
lation has no demonstrable effect on diurnal varia-
tion of plasma cortisol concentrations.
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